PHVS insider trading
NasdaqGS HealthcarePharvaris N.V.: insider trade history from SEC Form 4 filings.
About Pharvaris N.V.
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Company website: pharvaris.com
PHVS insider activity at a glance
FilingIQ tracks 127 insider transactions for PHVS in filings since Apr 3, 2026. The most recent transaction is dated Sep 23, 2026.
Across the full history, 0 open-market purchases
and 71 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PHVS insider trades is 60.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PHVS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading PHVS
Frequently asked
- How many insider trades does FilingIQ track for PHVS?
- FilingIQ tracks 127 Form 4 insider transactions for PHVS (Pharvaris N.V.), covering filings from Apr 3, 2026 onwards. 42 of those are dated within the last 90 days.
- Are PHVS insiders net buyers or net sellers?
- Across the full Form 4 history for PHVS, 0 transactions (0%) were open-market purchases and 71 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PHVS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PHVS in?
- Pharvaris N.V. (PHVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86B.
Methodology & sources
Every PHVS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.